Es gab 50 kürzliche Insider-Transaktionen für Disc Medicine, Inc. (IRON), darunter 15 Käufe und 35 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $19.3M und die gesamten Insider-Verkäufe auf $67.15M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Savage William Jacob, Franchi Jean M., Quisel John D. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — IRON
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-02 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
2,986 |
$66.41 |
$198.3K |
85,211 |
| 2026-02-25 |
Franchi Jean M. |
Chief Financial Officer |
Informierter Verkauf |
353 |
$69.06 |
$24.38K |
70,990 |
| 2026-02-18 |
Franchi Jean M. |
Chief Financial Officer |
Informierter Verkauf |
3,684 |
$65.89 |
$242.73K |
71,343 |
| 2026-02-17 |
Quisel John D |
Chief Executive Officer |
Informierter Verkauf |
13,264 |
$62.86 |
$833.78K |
226,064 |
| 2026-02-17 |
Stephenson Pamela |
Chief Commercial Officer |
Informierter Verkauf |
5,531 |
$62.86 |
$347.68K |
80,998 |
| 2026-02-17 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
Informierter Verkauf |
3,231 |
$62.86 |
$203.1K |
54,324 |
| 2026-02-17 |
Khara Rahul |
Chief Legal Officer |
Informierter Verkauf |
2,853 |
$62.86 |
$179.34K |
52,173 |
| 2026-02-17 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
3,256 |
$62.86 |
$204.67K |
92,589 |
| 2026-02-17 |
Franchi Jean M. |
Chief Financial Officer |
Informierter Verkauf |
4,075 |
$62.86 |
$256.15K |
78,424 |
| 2026-02-10 |
Quisel John D |
Chief Executive Officer |
RSU-Zuteilung |
82,800 |
$74.75 |
$6.19M |
82,800 |
| 2026-02-10 |
Franchi Jean M. |
Chief Financial Officer |
RSU-Zuteilung |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Stephenson Pamela |
Chief Commercial Officer |
RSU-Zuteilung |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
RSU-Zuteilung |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Khara Rahul |
Chief Legal Officer |
RSU-Zuteilung |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Savage William Jacob |
Chief Medical Officer |
RSU-Zuteilung |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-01-20 |
Khara Rahul |
Chief Legal Officer |
Optionsausübung (Verkauf) |
1,000 |
$13.50 |
$13.5K |
21,270 |
| 2026-01-02 |
Khara Rahul |
Chief Legal Officer |
Optionsausübung (Verkauf) |
6,500 |
$13.50 |
$87.75K |
22,270 |
| 2025-12-22 |
Savage William Jacob |
Chief Medical Officer |
Optionsausübung (Verkauf) |
219 |
$9.86 |
$2.16K |
2,628 |
| 2025-12-19 |
Quisel John D |
Chief Executive Officer |
Optionsausübung |
12,300 |
$1.01 |
$12.42K |
184,128 |
| 2025-12-17 |
Bitterman Kevin |
Director |
Informierter Verkauf |
148 |
$91.47 |
$13.54K |
14,013 |
| 2025-12-16 |
Bitterman Kevin |
Director |
Informierter Verkauf |
14,359 |
$91.24 |
$1.31M |
14,161 |
| 2025-12-15 |
Bitterman Kevin |
Director |
Optionsausübung (Verkauf) |
7,000 |
$13.50 |
$94.5K |
- |
| 2025-12-15 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
300 |
$92.23 |
$27.67K |
75,702 |
| 2025-12-12 |
Bitterman Kevin |
Director |
Informierter Verkauf |
1,371 |
$93.80 |
$128.6K |
41,519 |
| 2025-12-11 |
Quisel John D |
Chief Executive Officer |
Optionsausübung (Verkauf) |
40,000 |
$9.86 |
$394.4K |
75,375 |
| 2025-11-11 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
Optionsausübung (Verkauf) |
30,000 |
$2.65 |
$79.5K |
7,941 |
| 2025-10-22 |
Ai Dmi Llc |
10 Percent Owner |
Informierter Verkauf |
744,047 |
$80.47 |
$59.87M |
2,814,379 |
| 2025-10-17 |
Bitterman Kevin |
Director |
Informierter Verkauf |
450 |
$91.88 |
$41.35K |
385,549 |
| 2025-10-16 |
Bitterman Kevin |
Director |
Informierter Verkauf |
1,425 |
$77.11 |
$109.88K |
477,036 |
| 2025-10-15 |
Bitterman Kevin |
Director |
Informierter Verkauf |
2,618 |
$77.76 |
$203.58K |
478,461 |
| 2025-10-08 |
Bitterman Kevin |
Director |
Informierter Verkauf |
12,386 |
$69.31 |
$858.47K |
551,977 |
| 2025-10-07 |
Bitterman Kevin |
Director |
Informierter Verkauf |
6,661 |
$69.01 |
$459.68K |
572,582 |
| 2025-06-16 |
Franchi Jean M. |
Chief Financial Officer |
Informierter Verkauf |
2,000 |
$52.26 |
$104.52K |
67,530 |
| 2025-06-11 |
Gemayel Georges |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Ratcliffe Liam |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Bitterman Kevin |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Chin Mark |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
White William Richard |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Ashiya Mona |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Nicholson Donald William |
Director |
RSU-Zuteilung |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-06 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
2,996 |
$50.00 |
$149.8K |
56,725 |
| 2025-05-20 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
6,677 |
$50.04 |
$334.13K |
59,721 |
| 2025-05-02 |
Savage William Jacob |
Chief Medical Officer |
Informierter Verkauf |
2,100 |
$50.17 |
$105.37K |
66,398 |
| 2025-04-07 |
Quisel John D |
Chief Executive Officer |
Optionsausübung |
7,000 |
$1.01 |
$7.07K |
161,828 |
| 2025-03-24 |
Orbimed Advisors Llc |
Director |
Informierter Verkauf |
756 |
$54.11 |
$40.91K |
186,541 |
| 2025-03-24 |
Ashiya Mona |
Director |
Informierter Verkauf |
756 |
$54.11 |
$40.91K |
186,541 |
| 2025-03-21 |
Orbimed Advisors Llc |
Director |
Informierter Verkauf |
1,320 |
$54.00 |
$71.28K |
187,297 |
| 2025-03-21 |
Ashiya Mona |
Director |
Informierter Verkauf |
1,320 |
$54.00 |
$71.28K |
187,297 |
| 2025-03-20 |
Orbimed Advisors Llc |
Director |
Informierter Verkauf |
364 |
$54.01 |
$19.66K |
188,617 |
| 2025-03-20 |
Ashiya Mona |
Director |
Informierter Verkauf |
364 |
$54.01 |
$19.66K |
188,617 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
